Related Experiment Video
Updated: Mar 19, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Uremic Toxins - Novel Arrhythmogenic Factor in Chronic Kidney Disease - Related Atrial Fibrillation
Shih-Yu Huang1, Yi-Ann Chen2, Shih-Ann Chen3
1Graduate Institute of Clinical Medicine, Taipei Medical University, Taipei; ; Fu Jen Catholic University, School of Medicine, New Taipei City; ; Division of Cardiology, Department of Internal Medicine, Cathay General Hospital, Taipei;
Insights
Uremic toxins in chronic kidney disease (CKD) promote atrial fibrillation (AF) through cardiac tissue damage. This review explores how these toxins cause structural and electrical changes, leading to AF in CKD patients.
Area of Science:
- Cardiology
- Nephrology
- Toxicology
Background:
- Atrial fibrillation (AF) is a common arrhythmia.
- Chronic kidney disease (CKD) significantly increases AF prevalence.
- Uremic toxins are key contributors to cardiovascular disease in CKD.
Purpose of the Study:
- To review the mechanisms by which uremic toxins induce AF in CKD patients.
- To examine clinical, molecular, and electrophysiological data linking uremic toxins to AF.
- To understand the role of uremic toxins in cardiac remodeling.
Main Methods:
- Literature review of clinical studies.
- Analysis of molecular pathways involved in uremic toxicity.
- Electrophysiological data assessment.
Main Results:
- Uremic toxins induce pro-fibrotic, pro-hypertrophic, and pro-inflammatory effects on cardiac tissue.
- These toxins enhance oxidative stress and neurohormonal activity, contributing to AF.
- Multiple mechanisms of structural and electrical remodeling are implicated.
Conclusions:
- Uremic toxins are significant arrhythmogenic factors in CKD.
- Understanding these mechanisms is crucial for managing AF in CKD patients.
- Further research into toxin-specific effects is warranted.
Abstract:
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Chronic kidney disease (CKD) is associated with a high prevalence of AF, and uremic toxins are an important risk factor for cardiovascular diseases associated with CKD. Uremic toxins can produce pro-fibrotic, pro-hypertrophic, and pro-inflammatory effects on cardiac tissues and enhance oxidative stress or neurohormonal phenomena of cardiovascular injury, which are recognized as arrhythmogenic factors of AF. This article reviews the clinical, molecular, and electrophysiological data of uremic toxins in CKD considered to induce AF through multiple mechanisms on structural and electrical remodeling of the cardiovascular system.
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Chronic Kidney Disease II: Clinical Manifestations
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology

